Biotech

All Articles

' Medical intuition' led FDA consultants to back Zevra's unusual condition med

.Zevra Therapies' rare illness medicine seems to be to become on the pathway to approval this fall a...

Pfizer takes $230M struck after axing failed DMD genetics treatment

.Pfizer's phase 3 Duchenne muscle dystrophy (DMD) gene therapy breakdown has actually blown a $230 t...

AC Immune finds 'spots' prospective in Alzheimer's medication data

.After greater than two decades of focus on neurodegenerative ailments, Swiss biotech air conditione...

GSK goes down ph. 2 HPV vaccine over lack of best-in-class prospective

.GSK has broken up a stage 2 human papillomavirus (HPV) injection coming from its pipeline after mak...

OS Treatments refiles $6M IPO to money HER2 drug, preclinical ADCs

.OS Therapies will note on the NYSE American sell substitution today through a $6.4 thousand IPO tha...

ALX's waning CD47 action cost sends sell spiraling down

.ALX Oncology's stage 2 stomach cancer cells response rate has damaged. After observing its CD47 blo...

Ionis axes eye health condition from intendeds of Roche-partnered possibility after records disappoint

.An Additional of Ionis Pharmaceuticals' crucial midphase readouts has fallen short of desires, cuin...

Biogen's chief executive officer pointed out no unsafe sell 2023. He's ready to be vibrant

.While Biogen's pharma peers are actually searching for late-stage assets along with little bit of t...

Instil refills pipeline in $2B biobucks manage ImmunOnco

.Instil Biography has actually been actually a biotech trying to find a pipe after it junked its own...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually restored civil liberties to a very early Alzheimer's condition course to Denali...